A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population

References

• Lin JT, Yu XZ, Cui DJ, et al. A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population. Zhonghua Jie He He Hu Xi Za Zhi 2004;27:455–9
   PubMedGoogle Scholar
• Glezen WP, Keitel WA, Taber LH, et al. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978–1989. Am J Epidemiol 1991;133(3): 296–304
   PubMed Web of Science ®Google Scholar
• Lalezari J, Campion K, Keene O, Silagy C. Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials. Arch Intern Med 2001;61(2):212–7
   Google Scholar
• Langley JM, Faughnan ME; Canadian Task Force on Preventive Health Care. Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 2004;171(10):1169–70
   Google Scholar
• Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22:778–82
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial [Neuraminidase Inhibitor Flu Treatment Investigator Group]. Lancet 2000;355(9218):1845–50
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial [US Oral Neuraminidase Study Group]. J Am Med Assoc 2000;283(8):1016–24
   PubMed Web of Science ®Google Scholar
• Li L, Cai B, Wang M, et al. A multicenter clinical trial on oseltamivir treatment of influenza. Chin J Int Med 2001;40:838–42
   PubMedGoogle Scholar
• Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20(2):127–33
   PubMed Web of Science ®Google Scholar
• Li L, Cai B, Wang M, Zhu Y. A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China. Chin Med J 2003;116(1):44–8
   PubMed Web of Science ®Google Scholar
• Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. B Med J 2003;326(7401):1235
   PubMed Web of Science ®Google Scholar
• Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980;112(6):798–811
   PubMed Web of Science ®Google Scholar
• Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 1998;158(6):645–50
   Google Scholar
• Upshur RE, Knight K, Goel V. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure. Am J Epidemiol 1999;149(1): 85–92
   Google Scholar
• Narukawa M, Minezaki K, Okubo M, Kario K. Impact of an influenza pandemic on the mortality of congestive heart failure in older Japanese: the 1998 Japanese influenza pandemic. J Am Geriatr Soc 2001;49(5):689–90
   PubMed Web of Science ®Google Scholar
• Peters Jr PH, Gravenstein S, Norwood P, et al. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc 2001;49(8): 1025–31
   PubMed Web of Science ®Google Scholar
• Bowles SK, Lee W, Simor AE, et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999–2000. J Am Geriatr Soc 2002;50:608–16
   PubMed Web of Science ®Google Scholar
• Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003;163(14):1667–72
   PubMed Web of Science ®Google Scholar
• Nordstrom BL, Sung I, Suter P, et al. Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir. Curr Med Res Opin 2005;21:761–8
   PubMed Web of Science ®Google Scholar
• O’Connor S, Rifkin D, Yang YH, et al. Physician control of pediatric antimicrobial use in Beijing, China, and its rural environs. Pediatr Infect Dis J 2001;20:679–84
   Google Scholar